CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C19504 | BRD-K53682606 | BRD-K53682606 | -- | -- | -- | Details |
| C19505 | BRD-K53700261 | BRD-K53700261 | -- | -- | -- | Details |
| C19506 | BRD-K53703060 | BRD-K53703060 | -- | -- | -- | Details |
| C19507 | BRD-K53706972 | BRD-K53706972 | -- | -- | -- | Details |
| C19508 | BRD-K53717076 | BRD-K53717076 | -- | -- | -- | Details |
| C19509 | BRD-K53717189 | BRD-K53717189 | -- | -- | -- | Details |
| C19510 | BRD-K53720386 | BRD-K53720386 | -- | -- | -- | Details |
| C19511 | BRD-K53725468 | BRD-K53725468 | -- | -- | -- | Details |
| C19512 | BRD-K53728687 | BRD-K53728687 | -- | -- | -- | Details |
| C19513 | BRD-K53732802 | VU-0365118-1 | -- | -- | -- | Details |
| C19514 | BRD-K53734668 | BIIB-057 | -- | -- | -- | Details |
| C19515 | BRD-K53737926 | amitriptyline | CHRM1; CHRM2; CHRM3; CHRM4; CHRM5; HRH1; HTR6; SLC6A2; SLC6A4 | Norepinephrine inhibitor; Serotonin reuptake inhibitor; Serotonin receptor antagonist; Norepinephrine reuptake inhibitor | -- | Details |
| C19516 | BRD-K53739837 | BRD-K53739837 | -- | -- | -- | Details |
| C19517 | BRD-K53740124 | BRD-K53740124 | -- | -- | -- | Details |
| C19518 | BRD-K53740625 | BRD-K53740625 | -- | -- | -- | Details |
| C19519 | BRD-K53748177 | BRD-K53748177 | -- | -- | -- | Details |
| C19520 | BRD-K53752646 | BRD-K53752646 | -- | -- | -- | Details |
| C19521 | BRD-K53756103 | BRD-K53756103 | -- | -- | -- | Details |
| C19522 | BRD-K53757555 | BRD-K53757555 | -- | -- | -- | Details |
| C19523 | BRD-K53765467 | empagliflozin | SLC5A2 | Sodium/glucose cotransporter inhibitor | -- | Details |
| C19524 | BRD-K53768630 | BRD-K53768630 | -- | -- | -- | Details |
| C19525 | BRD-K53770426 | BRD-K53770426 | -- | -- | -- | Details |
| C19526 | BRD-K53771043 | BRD-K53771043 | -- | -- | -- | Details |
| C19527 | BRD-K53772256 | BRD-K53772256 | -- | -- | -- | Details |
| C19528 | BRD-K53774433 | BRD-K53774433 | -- | -- | -- | Details |
| C19529 | BRD-K53774864 | BRD-K53774864 | -- | -- | -- | Details |
| C19530 | BRD-K53780220 | BRD-K53780220 | -- | -- | -- | Details |
| C19531 | BRD-K53783288 | BRD-K53783288 | -- | -- | -- | Details |
| C19532 | BRD-K53790075 | BRD-K53790075 | -- | -- | -- | Details |
| C19533 | BRD-K53790871 | triamcinolone | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
| C19534 | BRD-K53792011 | BRD-K53792011 | -- | -- | -- | Details |
| C19535 | BRD-K53792571 | inhibitor-BEC | ARG1; ARG2 | Arginase inhibitor | inhibitor-bec | Details |
| C19536 | BRD-K53797069 | BRD-K53797069 | -- | -- | -- | Details |
| C19537 | BRD-K53798768 | BRD-K53798768 | -- | -- | -- | Details |
| C19538 | BRD-K53802078 | BRD-K53802078 | -- | -- | -- | Details |
| C19539 | BRD-K53803963 | BRD-K53803963 | -- | -- | -- | Details |
| C19540 | BRD-K53808186 | BRD-K53808186 | -- | -- | -- | Details |
| C19541 | BRD-K53813421 | BRD-K53813421 | -- | -- | -- | Details |
| C19542 | BRD-K53814023 | BRD-K53814023 | -- | -- | -- | Details |
| C19543 | BRD-K53814070 | ripasudil | ROCK1; ROCK2 | Rho associated kinase inhibitor | -- | Details |
| C19544 | BRD-K53815609 | nitrofural | -- | -- | -- | Details |
| C19545 | BRD-K53816294 | BRD-K53816294 | -- | -- | -- | Details |
| C19546 | BRD-K53816426 | BRD-K53816426 | -- | -- | -- | Details |
| C19547 | BRD-K53821452 | BRD-K53821452 | -- | -- | -- | Details |
| C19548 | BRD-K53833301 | BRD-K53833301 | -- | -- | -- | Details |
| C19549 | BRD-K53833823 | BRD-K53833823 | -- | -- | -- | Details |
| C19550 | BRD-K53839527 | BRD-K53839527 | -- | -- | -- | Details |
| C19551 | BRD-K53847315 | methylethylketoxime | -- | -- | -- | Details |
| C19552 | BRD-K53855319 | SRT-1720 | SIRT1 | SIRT activator | -- | Details |
| C19553 | BRD-K53857191 | risperidone | ADRA1B; ADRA1A; DRD2; DRD3; DRD4; HRH1; HTR1A; HTR1D; HTR2A; HTR2C | Dopamine receptor antagonist; Serotonin receptor antagonist | -- | Details |
| C19554 | BRD-K53861829 | BRD-K53861829 | -- | -- | -- | Details |
| C19555 | BRD-K53867114 | BRD-K53867114 | -- | -- | -- | Details |
| C19556 | BRD-K53867540 | BRD-K53867540 | -- | -- | -- | Details |
| C19557 | BRD-K53868452 | BRD-K53868452 | -- | -- | -- | Details |
| C19558 | BRD-K53873629 | BRD-K53873629 | -- | -- | -- | Details |
| C19559 | BRD-K53874318 | BRD-K53874318 | -- | -- | -- | Details |
| C19560 | BRD-K53878242 | MMPX | -- | -- | -- | Details |
| C19561 | BRD-K53888148 | DASB | -- | -- | dasb | Details |
| C19562 | BRD-K53889798 | BRD-K53889798 | -- | -- | -- | Details |
| C19563 | BRD-K53893978 | BRD-K53893978 | -- | -- | -- | Details |
| C19564 | BRD-K53896147 | BRD-K53896147 | -- | -- | -- | Details |
| C19565 | BRD-K53900606 | BRD-K53900606 | -- | -- | -- | Details |
| C19566 | BRD-K53901855 | BRD-K53901855 | -- | -- | -- | Details |
| C19567 | BRD-K53903639 | CHEMBL-1222381 | CAMK2A | Neural stem cell inducer | -- | Details |
| C19568 | BRD-K53904461 | BRD-K53904461 | -- | -- | -- | Details |
| C19569 | BRD-K53912655 | BRD-K53912655 | -- | -- | -- | Details |
| C19570 | BRD-K53913732 | SB-408124 | HCRTR1 | Orexin receptor antagonist | -- | Details |
| C19571 | BRD-K53914164 | BRD-K53914164 | -- | -- | -- | Details |
| C19572 | BRD-K53914319 | BRD-K53914319 | -- | -- | -- | Details |
| C19573 | BRD-K53914976 | BRD-K53914976 | -- | -- | -- | Details |
| C19574 | BRD-K53920100 | BRD-K53920100 | -- | -- | -- | Details |
| C19575 | BRD-K53923090 | BRD-K53923090 | -- | -- | -- | Details |
| C19576 | BRD-K53923665 | BRD-K53923665 | -- | -- | -- | Details |
| C19577 | BRD-K53923750 | BRD-K53923750 | -- | -- | -- | Details |
| C19578 | BRD-K53923842 | BRD-K53923842 | -- | -- | -- | Details |
| C19579 | BRD-K53927732 | BRD-K53927732 | -- | -- | -- | Details |
| C19580 | BRD-K53930447 | BRD-K53930447 | -- | -- | -- | Details |
| C19581 | BRD-K53931115 | BRD-K53931115 | -- | -- | -- | Details |
| C19582 | BRD-K53931904 | BRD-K53931904 | -- | -- | -- | Details |
| C19583 | BRD-K53932786 | BRD-K53932786 | -- | -- | -- | Details |
| C19584 | BRD-K53934736 | BRD-K53934736 | -- | -- | -- | Details |
| C19585 | BRD-K53936012 | BRD-K53936012 | -- | -- | -- | Details |
| C19586 | BRD-K53943097 | BRD-K53943097 | -- | -- | -- | Details |
| C19587 | BRD-K53943507 | BRD-K53943507 | -- | -- | -- | Details |
| C19588 | BRD-K53946803 | BRD-K53946803 | -- | -- | -- | Details |
| C19589 | BRD-K53949821 | BRD-K53949821 | -- | -- | -- | Details |
| C19590 | BRD-K53953065 | BRD-K53953065 | -- | -- | -- | Details |
| C19591 | BRD-K53955171 | BRD-K53955171 | -- | -- | -- | Details |
| C19592 | BRD-K53959060 | indirubin | CDK5; GSK3A; CDK1 | CDK inhibitor; GSK-3 inhibitor | -- | Details |
| C19593 | BRD-K53959928 | BRD-K53959928 | -- | -- | -- | Details |
| C19594 | BRD-K53963539 | vortioxetine | HTR1A; HTR1B; HTR1D; HTR7; SLC6A4 | Serotonin receptor agonist; Serotonin receptor antagonist | -- | Details |
| C19595 | BRD-K53971345 | BRD-K53971345 | -- | -- | -- | Details |
| C19596 | BRD-K53972329 | ruxolitinib | -- | -- | -- | Details |
| C19597 | BRD-K53978514 | BRD-K53978514 | -- | -- | -- | Details |
| C19598 | BRD-K53978628 | BRD-K53978628 | -- | -- | -- | Details |
| C19599 | BRD-K53979406 | ALX-5407 | SLC6A9 | Glycine transporter inhibitor | -- | Details |
| C19600 | BRD-K53980138 | BRD-K53980138 | -- | -- | -- | Details |
| C19601 | BRD-K53985154 | BRD-K53985154 | -- | -- | -- | Details |
| C19602 | BRD-K53986871 | BRD-K53986871 | -- | -- | -- | Details |
| C19603 | BRD-K53987533 | fluphenazine | DRD1; DRD2 | Dopamine receptor antagonist | -- | Details |